Gregory Tourangeau's most recent trade in Fulcrum Therapeutics Inc was a trade of 498 Common Stock done at an average price of $5.1 . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.06 per share. | 08 May 2025 | 498 | 14,062 (0%) | 0% | 5.1 | 2,520 | Common Stock |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 76,120 | 76,120 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 May 2024 | 236 | 11,571 (0%) | 0% | 7.8 | 1,831 | Common Stock |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Vice President, Finance | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 08 Mar 2024 | 4,884 | 11,807 (0%) | 0% | 11.7 | 57,219 | Common Stock |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 83,820 | 83,820 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Tourangeau Gregory | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.31 per share. | 10 May 2023 | 210 | 15,992 (0%) | 0% | 3.3 | 695 | Common Stock |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 16,100 | 16,100 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 16,540 | 16,540 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 6,500 | 6,500 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Gregory Tourangeau | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 3,250 | 16,202 (0%) | 0% | 0 | Common Stock |